Parecoxib Sodium is one of our company's declared imported API varieties. Welcome to consult and cooperate with major companies.

　　【Name】: Parecoxib Sodium

　　【Main ingredient】：ParecoxibNa

　　【Indications】: Used for short-term treatment of pain after surgery. Before deciding to use a selective COX-2 inhibitor, the overall risk of the patient should be assessed.

　　Parecoxib sodium is a non-steroidal anti-inflammatory drug. It is the world's first selective cyclooxygenase-2 (COX-2) inhibitor that can be injected intravenously and intramuscularly at the same time. It is combined with traditional non-selective cyclooxygenase Compared with enzyme inhibitors, it has the characteristics of good analgesic effect, rapid onset, long-lasting effect, effective inhibition of hyperalgesia, high gastrointestinal safety, no effect on platelet function, and no additional cardiovascular risk.

　　Parecoxib sodium was originally developed by Pfizer and Pharmacia, and was approved for marketing in Europe in 2002. In May 2008, parecoxib sodium for injection was approved to be marketed in China under the trade name Teraine. Since its launch, the drug has been recommended by authoritative clinical guidelines at home and abroad, and is widely used in the short-term treatment of postoperative pain in many departments such as orthopedics, general surgery, hepatobiliary surgery, urology, thoracic surgery, and obstetrics and gynecology.

　　TOSUN pharm, as a raw material drug import registration expert, focuses on the international pharmaceutical market, based on the domestic market demand, is committed to the import registration of excellent foreign raw material drugs, and conducts joint declarations with domestic manufacturers. The products cover cardiovascular, anti-tumor, antibiotic, anti-psychotic, gastrointestinal, ophthalmology and respiratory system medicine and other fields. Product quality standards meet or exceed USP/BP/EP/CP and other requirements. Most products have DMF, CEP and other documents, which are your preferred source of APIs for new product development and formulation production.

　　In addition, through the formation of pharmaceutical alliances with preparation manufacturers or R&D institutions (CROs) in various countries, our company can quickly meet the needs of drug R&D registration, solve difficult APIs, improve the speed of new product launches, and ensure market competitiveness. One-stop service from R&D to registered production. TOSUN pharm looks forward to creating a better future with you!